Acadia Pharmaceuticals Inc (ACAD)
R&D Expense Growth
6.10%
Quarterly · Period ending:
ACAD R&D Expense Growth
Latest reported6.10%period ending
Latest reported6.10%period ending
ACAD Quarterly R&D Growth (QoQ) (0.00% → 6.10%)
Latest values, visible window
High-resolution chart · PNG
ACAD r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 6.0975% | |
| -9.3078% | |
| -3.4977% | |
| 12.6721% | |
| -0.4012% | |
| -22.303% | |
| 51.2341% | |
| -12.6284% | |
| 27.7384% | |
| -10.5812% | |
| -57.4798% | |
| 167.0756% | |
| -15.002% | |
| -8.7063% | |
| -6.8826% | |
| 7.5219% | |
| -41.2937% | |
| 92.4875% | |
| 14.3038% | |
| 2.8629% | |
| -0.0667% | |
| -8.2797% | |
| -48.2724% | |
| 86.7688% | |
| -11.4833% | |
| 26.2796% | |
| -8.1473% | |
| -6.9786% | |
| 27.2037% | |
| 9.8375% | |
| -9.2804% | |
| 13.9938% | |
| 18.6272% | |
| -9.0391% | |
| 18.5552% | |
| 6.5565% | |
| -3.4709% | |
| 17.1785% | |
| 17.065% | |
| 26.0523% | |
| -10.0856% | |
| 11.2821% | |
| 9.2744% | |
| 1.9043% | |
| 12.7892% | |
| -10.3784% | |
| 7.2558% | |
| 22.8495% | |
| 18.2636% | |
| 47.2303% | |
| 9.2501% | |
| 1.9966% | |
| 60.5418% | |
| -9.6103% | |
| 11.3864% | |
| -1.61% | |
| -10.9341% | |
| 13.4946% | |
| 6.3973% | |
| -3.6385% | |
| -2.1985% | |
| -7.2525% | |
| -4.1893% | |
| -1.5076% | |
| -13.3104% | |
| -25.7912% | |
| -14.9647% | |
| -23.0737% | |
| -4.5802% | |
| 3.3591% | |
| -9.3379% | |
| -16.4567% | |
| 5.7017% | |
| -12.1947% | |
| 2.1823% | |
| 47.0987% | |
| -6.2475% | |
| 12.2905% | |
| -32.1759% | |
| 31.3668% | |
| 21.0251% | |
| 0.2148% | |
| 25.2874% | |
| 22.8825% | |
| 7.3174% | |
| -4.0675% | |
| 7.6259% | |
| 9.555% | |
| -5.9607% | |
| 0% | |
| 0% | |
| -100% | |
| 4.6699% | |
| 0% |